Dr. Kaitlyn Enright
Clinical innovation department
Dr. Enright has overseen clinical trials across all phases in over 24 countries. Her expertise includes preparation of international regulatory submissions, development of clinical evidence programs, trial design and oversight, pharmacovigilance and adverse event surveillance, and evidence synthesis for both industry and academic stakeholders.
She holds a PhD in Experimental Surgery from McGill University, where her doctoral research led to the development of the Global Registry of Adverse Clinical Events (GRACE), an electronic system designed to improve the reporting and tracking of complications in aesthetic medicine. Dr. Enright has authored numerous peer-reviewed publications, contributed to invited book chapters with Springer Nature, and regularly serves as a reviewer for Q1/2 scientific journals. Her work has contributed to advancing evidence-based safety standards and best practices in aesthetic medicine.